Our findings suggest that pharmacological inhibition of PIKfyve and the novel PIP5K1C could represent an effective therapeutic strategy for preventing infection by SARS-CoV-2 or its variants and for preparing for future pandemics. Here, PIKFYVE is linked to infection.